SIRT1 and cancer: Here, we identified FR58P1a, a new mild OXPHOS uncoupler that actives the Sirt1/AMPK axis and triggers a metabolic adaptation toward glycolysis, that promotes cancer cell survival but selectively decreases the migratory capability of TNBC cells.